DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS










 Company News
Sinovac Biotech Ltd. (SVA)'s EV71 Vaccine Phase III Clinical Trial Results Published In The New England Journal of Medicine 2/27/2014 9:49:02 AM    More...
The New England Journal of Medicine Reviews CareFusion Corporation's Chloraprep Study In Patient Safety Controversy 1/30/2014 9:26:59 AM    More...
Inspire Medical Systems’s STAR Clinical Trial Results Published In The New England Journal of Medicine 1/9/2014 8:24:49 AM    More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: The New England Journal of Medicine Publishes Pivotal Data Demonstrating Prophylactic Infusions Of ALPROLIX™ Effectively Controlled Bleeding In Hemophilia B Patients 12/5/2013 7:58:43 AM    More...
The New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax, Inc. (NVAX)' Vaccine Against H7N9 Avian Flu 11/14/2013 12:46:38 PM    More...
Celgene International Sárl (CELG) Release: ABRAXANE® Phase III Study of Patients With Metastatic Pancreatic Cancer Published in The New England Journal of Medicine 10/17/2013 11:11:19 AM    More...
Alnylam Pharmaceuticals (ALNY) and Collaborators Publish Clinical Trial Results With RNAi Therapeutics Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR) in The New England Journal of Medicine 8/29/2013 10:16:58 AM    More...
Celgene International Sárl (CELG) Release: Study of REVLIMID® (lenalidomide) in Patients with High-Risk Asymptomatic Smoldering Multiple Myeloma Published in The New England Journal of Medicine 8/1/2013 11:08:38 AM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F) Release: The New England Journal of Medicine Publishes Results From the Phase III ALSYMPCA Study of Xofigo® (Radium Ra 223 Dichloride) Injection 7/18/2013 8:35:34 AM    More...
No More Chemo? Molecularly Targeted Therapies Poised to Make Chemotherapy Obsolete in Treating Cancer, The New England Journal of Medicine Reveals 6/28/2013 8:23:27 AM    More...
12345678910...